Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Key Points GAAP earnings per share were $0.60 for Q2 2025, beating analyst expectations of $0.57. GAAP revenue reached $64.2 million, surpassing estimates and up 15% year over year (organic, non-GAAP) ...

Key Points GAAP earnings per share and revenue missed analyst expectations for Q2 2025 and declined from the prior year. Gross margin (GAAP) improved by 1.7 percentage points in Q2 2025 compared to ...

Advanced Micro Devices, Inc. sees strong Q2 revenue growth led by gaming, but margin compression impacts profits. Click for ...

ASX:BPT 1 Year Share Price vs Fair Value Explore Beach Energy's Fair Values from the Community and select yours ...

TSX:TRP 1 Year Share Price vs Fair Value Explore TC Energy's Fair Values from the Community and select yours TC ...

The company put up a bottom-line revenue that not only exceeded Wall Street expectations, but also its own history of ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

U.S. commercial revenue skyrocketed 93% year over year on phenomenal demand for the company's artificial intelligence ...

Pfizer boosted its profit outlook for the year following gains to its top- and bottom-line in its latest quarter.

It reported adjusted earnings per share of $1.44, missing Wall Street estimates of $1.46, and revenue of $1.93 billion, below projections of $1.94 billion.